Skip to main content
PFE logo

PFE · Pfizer Inc · Analyst Estimates

Track PFE — free
$28.59 -0.13 (-0.45%) At close · Sep 30
Market Cap
$163.41B
Shares
5.70B
Volume · Sep 30 33.65M Avg daily vol (3M) 37.77M

Analyst Estimates

Compare analyst forecasts for Pfizer Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-26 17:28 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.88
2.97497
3.1
—
2.97515
2.94721
2.97515
2.9589
— — — —
EPS
analysts
Publication date not stated
— — —
25
— — — —
4
1
15
6
Revenue
USD
Publication date not stated
61159000000
62235308250
63891000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
25
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.52
2.89684
3.16
—
2.8954
2.82949
2.897
2.82919
— — — —
EPS
analysts
Publication date not stated
— — —
25
— — — —
4
1
15
5
Revenue
USD
Publication date not stated
57803336450
59766396130
62493137230
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
24
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.59
0.75885
0.94
—
0.75889
0.81546
0.75889
0.84855
— — — —
EPS
analysts
Publication date not stated
— — —
18
— — — —
14
4
1
0
Revenue
USD
Publication date not stated
14985000000
15949285720
16852000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.59627
0.70814
0.814
—
0.70821
0.70084
0.70821
0.68835
— — — —
EPS
analysts
Publication date not stated
— — —
18
— — — —
4
2
11
2
Revenue
USD
Publication date not stated
16116000000
16871339639
18106000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
15
— — — — — — — —
Key facts CIK 78003 CUSIP 717081103 13F (30d) 85 filings 33 filers Visit website Investor relations